Paritaprevir
Preliminary reference disclaimer
This preliminary safety reference is generated from structured MolGraph catalog fields and public reference-style data. It is not a supplier-issued Safety Data Sheet and should not be used as a substitute for supplier-issued documentation, workplace safety review, transport classification, or regulatory compliance decisions. For supplier SDS or COA, submit a documentation request through MolGraph.
Preliminary safety reference
Available
Supplier-issued SDS
Available by request
COA
Available by RFQ / lot confirmation
Transport classification
Requires shipment review
CAS Number
1216941-48-8
Chemical name
Paritaprevir
Molecular formula
C40H43N7O7S
Molecular weight
765.9 g/mol
Synonyms
Veruprevir; Veruprevir anhydrous; ABT 450; VIEKIRAX COMPONENT PARITAPREVIR; empty; paritaprevirum; (1S,4R,6S,7Z,14S,18R)-N-cyclopropylsulfonyl-14-((5-methylpyrazine-2-carbonyl)amino)-2,15-dioxo-18-phenanthridin-6-yloxy-3,16-diazatricyclo(14.3.0.04,6)nonadec-7-ene-4-carboxamide; Paritaprevir (ABT-450); Paritaprevir(ABT-450); Veruprevir [INN]; Paritaprevir [USAN]; Paritaprevir [USAN:INN]
InChIKey
UAUIUKWPKRJZJV-QPLHLKROSA-N
PubChem CID
45110509
Signal word
Warning
Catalog reference cue; confirm supplier documentation before use.
Hazard statements
H302, H315, H319, H335
Catalog reference cue; confirm supplier documentation before use.
XLogP
4.7
Catalog reference value; verify against supplier SDS before use.
Shipment review
Shipment details require review before fulfillment.
Transport classification must be confirmed using supplier SDS and shipment documentation before dispatch.